Montelimar

Researchers are studying women with non-metastatic breast cancer who are undergoing adjuvant hormone therapy. The trial aims to compare the effects of adding a therapeutic education program combined with nursing phone follow-up to the usual care on managing side effects during the first year of treatment. This supportive care approach focuses on improving patients quality of life and reducing adverse effects related to hormone therapy. Participants in the experimental group will receive conventional oncology follow-up plus an initial educational assessment day around the time they start hormone therapy. A nurse will work with each patient to set personalized goals and select appropriate workshops in an outpatient educational program. The control group will receive only the standard oncology follow-up without additional education or nursing support. During the study, participants will be monitored for adverse events, quality of life, sleep quality, medication use, treatment adherence, confidence in using hormone therapy, knowledge about their disease and treatment, satisfaction with care, and economic impacts. These measures will be assessed at baseline, 2 months, 6 months, and 12 months. The programs acceptability and patients use of non-drug management methods will also be evaluated over one year.